drugset
drugset / Trial / NCT02336347

A Phase 1 Study Comparing AVP-786 With AVP-923

NCT02336347 ↗

Phase 1 Completed 62 enrolled Otsuka Pharmaceutical Development & Commercialization, Inc.
RandomizedCrossoverTriple-blindOther

Summary

To compare pharmacokinetics (PK) of AVP-786 (deuterated \[d6\] dextromethorphan hydrobromide \[d6-DM\]/quinidine sulfate \[Q\]) to AVP-923 (dextromethorphan hydrobromide \[DM\]/Q) at steady state.

Timeline

Start
2014-05-01
Primary completion
2014-09-01
Completion
2015-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject AVP-786 Unknown — Oral
Comparator AVP-923 Unknown — Oral

Indications

No indication recorded.